Cookie Control

This site uses cookies to store information on your computer.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

By using our site you accept the terms of our Privacy Policy.

(One cookie will be set to store your preference)
(Ticking this sets a cookie to hide this popup if you then hit close. This will not store any personal information)

About this tool

About Cookie Control

        News       Events

 

ABPI launches new tool to help boost medical research

 

The Association of the British Pharmaceutical Industry (ABPI) has developed a new tool to help build research relationships between the pharmaceutical industry and UK academics.

Launched at the Francis Crick Institute in London [Monday 5 June], the Library of Initiatives for Novel Collaborations (ABPI LINC) – a research database – will provide easy access to identify new collaboration opportunities.

​​​​​​Using the database academics and clinical researchers can more easily identify opportunities online for collaboration with the biopharmaceutical industry including funding opportunities, access to cutting-edge equipment, compounds and opportunities to build collaborative relationships.

The database also provides, for the first time, a publicly available and user-friendly central portal to see the different ways pharmaceutical companies are supporting open innovation, working with researchers across the UK both in hospitals and in universities. 

You can search ABPI LINC by research stage (preclinical/clinical), type of collaboration or resource (e.g. sharing compounds, resources, funding, investigator led studies), disease area (e.g. infectious disease), or company.

For more see the ABPI website.

 

Back to top